These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23631169)

  • 21. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thrombotic risk factors and antithrombotic treatment in atrial fibrillation].
    Bounhoure JP
    Bull Acad Natl Med; 2011; 195(4-5):963-74; discussion 974-7. PubMed ID: 22375363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular diastolic dysfunction and thromboembolic risk in atrial fibrillation: diastolic dysfunction and thromboembolic risk in AF.
    Kosiuk J; Breithardt O; Bode K; Kornej J; Arya A; Gaspar T; Hindricks G; Bollmann A
    Int J Cardiol; 2013 Sep; 168(1):547-8. PubMed ID: 23453879
    [No Abstract]   [Full Text] [Related]  

  • 25. Etiology and pathogenesis of thromboembolism.
    Aronow WS
    Herz; 1991 Dec; 16(6):395-404. PubMed ID: 1765343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrosis: a risk stratifier for atrial fibrillation.
    Velagapudi P; Turagam MK; Leal MA; Kocheril AG
    Expert Rev Cardiovasc Ther; 2013 Feb; 11(2):155-60. PubMed ID: 23405837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thromboembolism risks in atrial fibrillation].
    Babuty D; Gorin L; Zannad N; Fauchier L
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S11-3. PubMed ID: 20103170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models.
    Nishida K; Chiba K; Iwasaki YK; Katsouras G; Shi YF; Blostein MD; Khairy P; Guerra PG; Dubuc M; Tardif JC; Tanguay JF; Nattel S
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1168-75. PubMed ID: 23095228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation.
    Chello M; Spadaccio C; Patti G; Lusini M; Barbato R; Goffredo C; Di Sciascio G; Covino E
    Atherosclerosis; 2008 Apr; 197(2):588-95. PubMed ID: 17904146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Ding WY; Gupta D; Lip GYH
    Heart; 2020 Oct; 106(19):1463-1468. PubMed ID: 32675218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional endocardial left atrial voltage and electrogram fractionation in patients with atrial fibrillation.
    Katritsis D; Sougiannis D; Giazitzoglou E; Kourlaba G; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1254-8. PubMed ID: 18665874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk stratification for thromboembolism and antithrombotic prophylaxis in atrial fibrillation].
    Di Pasquale G; Riva L
    G Ital Cardiol (Rome); 2012 Nov; 13(11 Suppl 1):11S-18S. PubMed ID: 23160015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
    Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers in atrial fibrillation: a clinical review.
    Hijazi Z; Oldgren J; Siegbahn A; Granger CB; Wallentin L
    Eur Heart J; 2013 May; 34(20):1475-80. PubMed ID: 23386711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis.
    Nakamura Y; Nakamura K; Fukushima-Kusano K; Ohta K; Matsubara H; Hamuro T; Yutani C; Ohe T
    Thromb Res; 2003; 111(3):137-42. PubMed ID: 14678810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.